Prevention strategies for prostate cancer

Minerva Urologica e Nefrologica

Volumn 64, Issue 4, 2012, Pages 225-231

  Schmitz Drager B J ^a   Lummen G ^b   Bismarck, E ^a   Fischer, C ^c   Alrwein, J ^d   Klotz, T ^d   Mathers, M J ^d   Rohde, V ^d   Schaefer, R ^d   Sommer, F ^d   Schroeder, A ^d   Thelen, P ^d  

^a Euromed Clinic   (Germany)

^b St Josef Hospital Troisdorf   (Germany)

^c Klinikum Hohe Warte   (Germany)

^d NONE

Author keywords

Nutrition; Primary prevention; Prostatic neoplasms; Vitamins

Indexed keywords

DUTASTERIDE; FINASTERIDE; STEROID 5ALPHA REDUCTASE;

CANCER DIAGNOSIS; CARCINOGENESIS; DAIRY PRODUCT; FOOD INTAKE; HUMAN; LIFESTYLE MODIFICATION; PROSTATE CANCER; REVIEW; SMOKING; VITAMIN SUPPLEMENTATION;

5-ALPHA REDUCTASE INHIBITORS; ADENOCARCINOMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BODY WEIGHT; DAIRY PRODUCTS; DIET; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIFE STYLE; MALE; MEAT; PHYTOESTROGENS; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SELENIUM; SMOKING CESSATION; VITAMINS;

EID: 84875311669     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Becker N. Epidemiologic aspects of cancer prevention in Germany. J Cancer Res Clin Oncol 2001;127:9-1.
2. Schmitz-Dräger BJ, Eichholzer M, Beiche B, Ebert T. Nutrition and prostate cancer. Urol Int 2001;67:1-11. (Pubitemid 32679649)
3. Brinkman M, Reulen RC, Kellen E, Buntinx F, Zeegers MP. Are men with low selenium levels at increased risk of prostate cancer? Eur J Cancer 2006;42:2463-71. (Pubitemid 44442953)
4. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301:39-51.
5. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the US Preventive Services Task Force. Ann Intern Med 2011;155:827-38.
6. Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011;306:1549-56.
7. Jiang L, Yang KH, Tian JH, Guan QL, Yao N, Cao N et al. Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: a meta-analysis of randomized controlled trials. Nutr Cancer 2010;62:719-27.
8. Stratton J, Godwin M. The effect of supplemental vitamins and minerals on the development of prostate cancer: a systematic review and meta-analysis. Fam Pract 2011;28:243-52.
9. Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst 2000;92:61-8. (Pubitemid 30082230)
10. Gonzalez CA. The European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 2006;9(1A):124-6.
11. Ilic D, Forbes KM, Hassed C. Lycopene for the prevention of prostate cancer. Cochrane Database Syst Rev 2011;11:CD008007.
12. Gonzalez CA, Riboli E. Diet and cancer prevention: Contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Cancer 2010;46:2555-62.
13. Cross AJ, Peters U, Kirsh VA, Andriole GL, Reding D, Hayes RB et al. A prospective study of meat and meat mutagens and prostate cancer risk. Cancer Res 2005;65:11779-84. (Pubitemid 41821740)
14. Qin LQ, Xu JY, Wang PY, Kaneko T, Hoshi K, Sato A. Milk consumption is a risk factor for prostate cancer: meta-analysis of case-control studies. Nutr Cancer 2004;48:22-7. (Pubitemid 38823543)
15. Newmark HL, Heaney RP. Dairy products and prostate cancer risk. Nutr Cancer 2010;62:297-9.
16. Wright ME, Bowen P, Virtamo J, Albanes D, Gann PH. Estimated phytanic acid intake and prostate cancer risk: A prospective cohort study. Int J Cancer 2011 [Epub ahead of print].
17. Moyad MA. Dietary fat reduction to reduce prostate cancer risk: controlled enthusiasm, learning a lesson from breast or other cancers, and the big picture. Urology 2002;59(4 Suppl 1):51-62. (Pubitemid 34286431)
18. MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM, Suttorp MJ et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 2006;295:403-15. (Pubitemid 43144977)
19. Zeegers MP, Dirx MJ, van den Brandt PA. Physical activity and the risk of prostate cancer in the Netherlands cohort study, results after 9.3 years of follow-up. Cancer Epidemiol Biomarkers Prev 2005;14:1490-5. (Pubitemid 40807351)
20. Johnsen NF, Tjønneland A, Thomsen BL, Christensen J, Loft S, Friedenreich C et al. Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Cancer 2009;125:902-8.
21. Koebnick C, Michaud D, Moore SC, Park Y, Hollenbeck A, Ballard-Barbash R et al. Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 2008;17:1214-21.
22. Moore SC, Chow WH, Schatzkin A, Adams KF, Park Y, Ballard-Barbash R et al. Physical activity during adulthood and adolescence in relation to renal cell cancer. Am J Epidemiol 2008;168:149-57. (Pubitemid 351951591)
23. Malila N, Virtanen MJ, Virtamo J, Albanes D, Pukkala E. Cancer incidence in a cohort of Finnish male smokers. Eur J Cancer Prev 2006;15:103-7. (Pubitemid 44145594)
24. Zu K, Giovannucci E. Smoking and aggressive prostate cancer: a review of the epidemiologic evidence. Cancer Causes Control 2009;20:1799-810.
25. Zeegers MP, Kellen E, Buntinx F, van den Brandt PA. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 2004;21:392-401.
26. Rota M, Scotti L, Turati F, Tramacere I, Islami F, Bellocco R et al. Alcohol consumption and prostate cancer risk: a meta-analysis of the dose-risk relation. Eur J Cancer Prev 2011 [Epub ahead of print].
27. Engeland A, Tretli S, Bjorge T. Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men. Br J Cancer 2003;89:1237-42. (Pubitemid 37363410)
28. MacInnis RJ, English DR. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 2006;17:989-1003. (Pubitemid 44290764)
29. Porter MP, Stanford JL. Obesity and the risk of prostate cancer. Prostate 2005;62:316-21. (Pubitemid 40224137)
30. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349:215-24. (Pubitemid 36859473)
31. Scardino P. The prevention of prostate cancer - the dilemma continues. N Engl J Med 2003:349:297-9.
32. Klotz L, Saad F; PCPT-MTOPS Consensus Panel. PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice. Can Urol Assoc J 2007;1:17-21.
33. Sarvis JA, Thompson IM. Prostate cancer chemoprevention: update of the prostate cancer prevention trial findings and implications for clinical practice. Curr Oncol Rep 2008;10:529-32.
34. Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F et al.; REDUCE Study Group. Effect of dutasteride on the risk of prostate cancer. N Engl J Med 2010;362:1192-202.
35. Wilt TJ, Macdonald R, Hagerty K, Schellhammer P, Tacklind J, Somerfield MR et al. 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review. BJU Int 2010;106:1444-51.
36. Jafari S, Etminan M, Afshar K. Nonsteroidal anti-inflammatory drugs and prostate cancer: a systematic review of the literature and meta-analysis. Can Urol Assoc J 2009:3:323-30.
37. Mahmud SM, Franco EL, Aprikian AG. Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis. Int J Cancer 2010;127:1680-91.
38. Price D, Stein B, Sieber P, Tutrone R, Bailen J, Goluboff E et al. Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial. J Urol 2006;176:965-70.
39. Bonovas S, Filioussi K, Sitaras NM. Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies. Int J Cancer 2008;123:899-904. (Pubitemid 352032419)
40. Farwell WR, Scranton RE, Lawler EV, Lew RA, Brophy MT, Fiore LD et al. The association between statins and cancer incidence in a veterans population. J Natl Cancer Inst 2008;100:134-9. (Pubitemid 351480564)
41. Schmitz-Dräger BJ, Bismarck E, Fischer C; Schöffski O. [Chemoprevention of prostate cancer - a plea]. Akt Urol 2012;43:157-61.